Abramson Cancer Center at the University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104-4283.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Abramson Cancer Center at the University of Pennsylvania has participated in 19 clinical trials with 8 currently active.
Therapeutic areas: Brain and Central Nervous System Tumors, Prostate Cancer, Multiple Myeloma and Plasma Cell Neoplasm.
Sponsors: New Approaches to Brain Tumor Therapy Consortium, Eastern Cooperative Oncology Group, Abramson Cancer Center at Penn Medicine.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer Center at the University of Pennsylvania has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer Center at the University of Pennsylvania has 19 clinical trials on record, with 8 currently active. Their work covers Brain and Central Nervous System Tumors, Prostate Cancer, Multiple Myeloma and Plasma Cell Neoplasm.
Yes — Abramson Cancer Center at the University of Pennsylvania holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.